Masonic Cancer Center, University Of Minnesota
Clinical trials sponsored by Masonic Cancer Center, University Of Minnesota, explained in plain language.
-
New hope for stem cell transplant patients: lower steroid doses with drug combo
Disease control TerminatedThis study tested a combination of three drugs (ruxolitinib, uhCG/EGF, and steroids) to treat severe acute graft-versus-host disease (GVHD), a serious complication after stem cell transplant. The goal was to find the lowest effective steroid dose to reduce side effects while stil…
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
Cord blood transplant shows promise for tough blood cancers
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It included 200 people and aimed to see how many survived one year after the transplant. The approach is intense and mean…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 02:48 UTC